Wird geladen...
Breakthrough venous thromboembolic events in five patients with COVID‐19 on direct oral anticoagulants
WHAT IS KNOWN AND OBJECTIVE: Coronavirus disease 2019 (COVID‐19) is associated with increased risk of venous thromboembolism (VTE). Guidance for VTE prophylaxis continues to evolve, including addressing direct oral anticoagulants (DOACs) continued upon hospitalization. CASE SUMMARIES: We present 5 p...
Gespeichert in:
| Veröffentlicht in: | J Clin Pharm Ther |
|---|---|
| Hauptverfasser: | , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
John Wiley and Sons Inc.
2020
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7753371/ https://ncbi.nlm.nih.gov/pubmed/33217032 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jcpt.13311 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|